
PhD student in Cancer Biology | Challen lab | Washington University in St. Louis @WashUCancerBio @challenlab
St Louis, MO
Joined December 2018
- Tweets36
- Following181
- Followers129
- Likes492
Aishwarya Krishnan retweeted
Irenaeus Chan representing the @WashUCancerBio program with style in the plenary session of #ASH25 !!
Aishwarya Krishnan retweeted
Explore the August Issue of #ExpHem including the first commentary on cell-extrinsic factors in Tet2-mutant clonal hematopoiesis from @lindemilesphd @challenlab @akrish0294 exphem.org/issue/S0301-472X(…
Aishwarya Krishnan retweeted
Excited to see the first commentary in Exp Hematology (@ISEHSociety)! Kudos to Aishwarya @akrish0294, Linde @lindemilesphd and Grant @challenlab for highlighting recent papers in @ELShematology on cell-extrinsic factors in Tet2-mutant clonal hematopoiesis. bit.ly/4k3pEAI
Aishwarya Krishnan retweeted
Fun times at Miami Nights 🌴☀️🌸 #ASH24
Aishwarya Krishnan retweeted
Interested in coevolution of independent driver clones in MPN/sAML? Come see what I've been up to in the @challenlab on Monday morning! We've been working on this for awhile and are excited to share it! @WashUHematology @WashUDeptMed @WashUOncology #ASH24 #mpnsm
Mentors, old and new, being recognized by @LLSusa for their incredible research and contributions to the field! So honored to have the privilege of being mentored by both these amazing scientists! Congrats 🎉 @rosslevinemd and @challenlab
1
18
519
Replying to @challenlab
@challenlab and @WashUCancerBio GR3 taking the retreat by storm!! #CBretreat2023 #cedarcreeklodge @InfenciaXR @Rachel_DeWeerd @AlexMabry0
Very excited to announce that I've been awarded the ASH Graduate Hematology Award by @ASH_hematology. A huge shout-out to @challenlab and team for all the support and guidance through this process!! #ASHAwards
Aishwarya Krishnan retweeted
Can't believe it's already the last week of September😯It means Tuesday Tea at two is happening tomorrow! Everyone is welcome to come by, grab some food or drink, hang out, decompress, and meet new people. We hope to see you tomorrow!
Aishwarya Krishnan retweeted
WiSTEM’s Community Outreach and Mentoring & Networking Committee are having a networking/mentoring event with WUSTL Scientista (a WashU undergraduate Women in the STEM student group.) If you are interested, please DM us for a signup link!
Aishwarya Krishnan retweeted
Happy to share our recent work now in Blood
on a mechanism of leukemic transformation of MPNs in context of Tp53 alterations (ashpublications.org/blood/ar…)
Aishwarya Krishnan retweeted
April Tea at two is happening NEXT TUESDAY! Take a break, grab some snacks, sip some tea, and hang out with WiSTEM members! See the flyer for details! BOYM, if possible🍵 bonus: we have coloring pages!👩🎨
Aishwarya Krishnan retweeted
Tea at two is BACK! Have an incubation time? Been plotting graphs all day? Take a break and come grab some snack, sip some tea, and hang out with WiSTEM members next Tuesday! See flyer for details! BOYM if possible🍵 bonus: we have coloring pages!👩🎨
From one heme lab to the next! Super excited for what's to come! #Leviner to #Challenger
Thanks again for the lab coat @sanchezvelamd
Double trouble. Welcoming the newest #Challengers to the lab @akrish0294 and @InfenciaXR part of the @WUSTLdbbs @WashUCancerBio program. Let’s do this!
1
1
Aishwarya Krishnan retweeted
Out today in Clinical Cancer Research (@CCR_AACR ), our preclinical study of combined JAK, CDK4/6, and PIM kinase inhibitors in MPN. clincancerres.aacrjournals.o… @MSKEducation @MSKCC_Library @akrish0294 @rosslevinemd @RichardKoche @ShoronMowla @RossLevineLab #mpnsm
Super excited to be starting at @WashUCancerBio this Fall!!! Can't wait to be a part of this incredible program!
Welcome Aishwarya Krishnan! Our fourth new PhD student in the Cancer Biology Program. Keep them coming!
3
9
Aishwarya Krishnan retweeted
Is there a role for combination SL-401 and Ruxolitinib in advanced MPN? Come to Aishwarya Krishnan’s poster this afternoon to learn more. #mpnsm @sloan_kettering @Stemline @rosslevinemd




























